NCT06743347

Brief Summary

This research will enhance our knowledge and understanding of Cerebrospinal Fluid (CSF) circulation around the Central Nervous System (CNS) (brain and spinal cord). The main objective is to obtain flow velocities using Phase Contrast (PC) MRI over the entire subarachnoid space (SAS). This will enable us to develop and validate a numerical model of the SAS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 16, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 19, 2024

Completed
9 months until next milestone

Study Start

First participant enrolled

September 24, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 17, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 17, 2025

Completed
Last Updated

January 5, 2026

Status Verified

January 1, 2026

Enrollment Period

3 months

First QC Date

December 16, 2024

Last Update Submit

January 2, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • To evaluate the velocity displacement of CSF about 7 planes (intracranial plane, C2-C3, C5-C6, T4-T5, T10-T11, L3-L4, L5-S1)

    Displacement velocities of CSF will be obtain by Phase Contrats MRI.

    Time PC-MRI will be around 60min

Secondary Outcomes (2)

  • Using morphological MRI to model a digital twin

    Time PC-MRI will be around 60min

  • To evaluate the velocity displacement of blood about 2 planes (intracranial plane, C2-C3)

    Time PC-MRI will be around 60min

Study Arms (1)

Phase Contrast MRI

EXPERIMENTAL
Other: MRI Contrast

Interventions

Pass a Phase Contrast MRI. No injection required.

Phase Contrast MRI

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years at the time of agreement
  • Free subject, without guardianship or curatorship or subordination
  • Patients benefiting from a Social Security scheme or benefiting from it through a third party
  • Informed consent signed by the patient after clear and complete information about the study

You may not qualify if:

  • T MRI contraindications (pacemaker, cochlear implant, metallic splinter, etc)
  • History of neurological pathology
  • Previous operations involving the central nervous system (spinal surgery, neurological surgery, etc.)
  • Current pathology or treatment that may interfere with the CSF or subarachnoid spaces (CSF dysregulation, disc herniation, hydrocephalus, Chiari malformation, etc.)
  • Concurrent participation in another clinical research study
  • Persons not covered by Social Security or not covered by Social Security through a third party
  • Persons benefiting from enhanced protection, namely minors, persons deprived of their liberty by a judicial or administrative decision, adults under legal protection
  • Pregnant or breastfeeding women, women of childbearing age who do not have effective contraception (hormonal/mechanical: oral, injectable, transcutaneous, implantable, intrauterine device, or surgical: tubal ligation, hysterectomy, total oophorectomy)
  • \- Discovery of a contraindication to 3T MRI (pacemaker, cochlear implant, metallic splinter, etc)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

C.H.U. Poitiers

Poitiers, 86000, France

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 16, 2024

First Posted

December 19, 2024

Study Start

September 24, 2025

Primary Completion

December 17, 2025

Study Completion

December 17, 2025

Last Updated

January 5, 2026

Record last verified: 2026-01

Locations